PATENT CLAIM ANALYSIS

Application Number: 15900147
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2019-03
Patent Classification: ["546", "156000"]

Abstract:
The present invention relates to solid state forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide (Compound 1), pharmaceutical compositions thereof and methods therewith.

Claim (Index 111):
The crystal form of  claim 105 , wherein the crystal form of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide is further characterized by a peak at about 18.6.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.07143
- Patent Class: 546.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14272692', '15584324', '14852892', '13785692', '13358778']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8189269751741283
- 35 USC 102 Novelty (BERT): 0.5589455004825478
- Combined Prediction Score: 0.7929288277049702
- Mean Citation Score: 410.55338
- Max Citation Score: 437.0347
- Similarity Product: 385.8746340633333

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test